![]() Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. | |||
Founding Date | Founding Date 2004 | Founding Date 1996 | Founding Date 2006 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US | Locations US HQ | Locations Uppsala, SE HQ Uppsala, SE Uppsala, SE |
Employees | Employees 194362% increase | Employees 433% increase | Employees 16 |
Valuation ($) | Valuation ($) 515.9 m | Valuation ($) 129.4 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $109.8m (FY, 2025) | Revenue (est.) $44.6m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($153.5m) (FY, 2025) | Net income ($9.7m) (FY, 2025) | Net income N/A |

Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
View companyBeactica is a company that specializes in fragment-based drug discovery.
View company